IMMOGYN
ActiveSummary
IMMOGYN has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,892 and a net result of €16,432. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 30% of 11,191 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
30-06
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-12
Financial
Highest result from 2019 to 2025net €16,656 ▲14.3%
Operating result €23,220, net result €16,656, both a record.
31-07
NBB filing
Annual accounts filed
financial year 2023 · full format
2023
25-10
Gazette deed
Resignation: KRIDELKA Frédéric Jean Léon Alex (director)Appointment: GynecoPP (director) · Permanent representative: PAQUAY Pauline · Reappointments: JOHNSON Stéphanie, WERY Olivier and 3 others22 facts ▸
Gazette deed
Resignation: KRIDELKA Frédéric Jean Léon Alex (director)
Appointment: GynecoPP (director) · Permanent representative: PAQUAY Pauline · Reappointments: JOHNSON Stéphanie, WERY Olivier and 3 others22 facts ▸
- General meeting, 19-10-2023
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible puis fonds disponibles pour distribution” (deed in French)
- Amendment of the articles, “21 alinéa 2” (deed in French)
- Capital
- Director resignation, KRIDELKA Frédéric Jean Léon Alex (director)
- Director appointment, GynecoPP (director (not named in the articles))
- Permanent representative, PAQUAY Pauline
- Director reappointment, JOHNSON Stéphanie (director (not named in the articles))
- Director reappointment, WERY Olivier (director (not named in the articles))
- Director reappointment, MERINDOL Céline (director (not named in the articles))
- Director reappointment, DOUPAGNE Alix (director (not named in the articles))
- +10 further facts in this act
22-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 22 days late
2022
31-12
Financial
Back to profitnet €15,085
Net result €15,085 after 3 loss-making years.
24-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 24 days late
2021
20-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Weakest financial yearnet -€28,379
Net result drops to -€28,379, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.